Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/51295
Title: | Rationale, Design, and Methodology of the MORCOR-TURK Trial: Predictors of In-hospital MORtality in CORonary Care Patients in Turkey | Authors: | Kahraman, Fatih Ersoy, İbrahim Yılmaz, Ahmet Seyda Atıcı, Adem Tekin, Alpin Mert Açar, Burak Kaya, Çağlar Kara, Faruk Kurt, Feyza Avcı Demir, Fulya Çerik, İdris Buğra Yılmaz, İshak Adalı, Mehmet Koray Yeni, Mehtap Taşcanov, Mustafa Beğenç Duz, Ramazan Gülaştı, Sevil Ömür, Sefa Topuz, Şahin Hidayet, Siho Kaçmaz, Yücel Aygül, Nazif |
Keywords: | clinical trial epidemiology hospital discharge hospital mortality hospitalization human multicenter study patient turkey (bird) Hospital Mortality Hospitalization Humans Patient Discharge Patients Turkey |
Publisher: | NLM (Medline) | Abstract: | BACKGROUND: Coronary care units are sophisticated clinics established to reduce deaths due to acute cardiovascular events. Current data on coronary care unit mortality rates and predictors of mortality in Turkey are very limited. The MORtality predictors in CORonary care units in TURKey (MORCOR-TURK) trial was designed to provide information on the mortality rates and predictors in patients followed in coronary care units in Turkey. METHODS: The MORCOR-TURK trial will be a national, observational, multicenter, and noninterventional study conducted in Turkey. The study population will include coronary care unit patients from 50 centers selected from all regions in Turkey. All consecutive patients admitted to coronary care units with cardiovascular diagnoses between 1 and 30 September 2022 will be prospectively enrolled. All data will be collected at one point in time, and the current clinical practice will be evaluated (ClinicalTrials.gov number NCT05296694). In the first step of the study, admission diagnoses, demographic characteristics, basic clinical and laboratory data, and in-hospital management will be assessed. At the end of the first step, the predictors and rates of in-hospital mortality will be documented. The second step will be in cohort design, and discharged patients will be followed up till 1 year. Predictors of short- and long-term mortality will be assessed. Moreover, a new coronary care unit mortality score will be generated with data acquired from this cohort. RESULTS: The short-term outcomes of the study are planned to be shared by early 2023. CONCLUSION: The MORCOR-TURK trial will be the largest and most comprehensive study in Turkey evaluating the rates and predictors of in-hospital mortality of patients admitted to coronary care units. | URI: | https://doi.org/10.14744/AnatolJCardiol.2022.2824 https://hdl.handle.net/11499/51295 |
ISSN: | 2149-2271 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
document - 2024-04-03T100504.028.pdf | 2.36 MB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
3
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
2
checked on Oct 20, 2024
Page view(s)
64
checked on Aug 24, 2024
Download(s)
6
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.